SYSTANE MAX owner Contact Information online
from NOVARTIS AG
SYSTANE MAX
US serial number:85048376
Application filling date:May 26, 2010
Register:Principal
Mark type:Trademark
Status:Registered. The registration date is used to determine when post-registration maintenance documents are due.
Status date:Apr. 12, 2011
Publication date:Jan. 25, 2011
Standard character claim:Yes. The mark consists of standard characters without claim to any particular font style, size, or color.
Mark drawing type:4 - STANDARD CHARACTER MARK
Foreign foreign registration number:603552
Foreign foreign registration date:Aug. 05, 2010
Foreign foreign application registration country:SWITZERLAND
Foreign foreign expiration date:May 25, 2020
Goods and services:For: Ophthalmic preparations
International Class(es): 005- Primary Class
U.S Class(es): 006,018,044,046,051,052
Class Status: ACTIVE
Basis: 44(e)
Services:Ophthalmic preparations
Current owner owner name:NOVARTIS AG
Current owner owner address:CH-4002
BASEL
SWITZERLAND
Current owner legal entity type:CORPORATION
Current owner state or country:SWITZERLAND
Attorney name:Catherine D. Murray
Attorney email:tm.services@alcon.com
Attorney email authorized:Yes
Correspondent name address:Stephanie Boyle
Alcon Laboratories, Inc.
6201 South Freeway
Fort Worth,
TEXAS
UNITED STATES
76134
Correspondent phone:817-551-6906
Correspondent email:tm.services@alcon.com
Correspondent fax:817-551-4373
Correspondent email authorized:Yes
Domestic representative name:Jennifer L. Dean
Domestic representative phone:817-551-6906
Domestic representative fax:817-551-4373
Domestic representative email:dctrademarks@dbr.com
Domestic representative email authorized SYSTANE MAX:Yes
Latest trademarks
Popular owners
Glaxo Group Limited (173) Novartis AG (147) JOHNSON & JOHNSON (125) Millennium Pharmaceuticals, Inc. (54) Eli Lilly and Company (53) Windmill Health Products, LLC (46) Bayer Aktiengesellschaft (44) SANOFI (41) Wyeth LLC (41) Pfizer Inc. (39) Bristol-Myers Squibb Company (34) Forest Laboratories, Inc. (34) Vital Health Pharmaceuticals, Inc. (31) Primary Investments Group Limited (28) S. C. Johnson & Son, Inc. (28) MERCK SHARP & DOHME CORP. (27) Futurebiotics, LLC (26) MONSTER ENERGY COMPANY (19) Scott Riddell (17) Biocept, Inc. (16)Popular publication dates
Jan. 25, 2011 Mar. 08, 2011 Mar. 15, 2011 Mar. 22, 2011 Mar. 29, 2011 Nov. 16, 2010 Apr. 19, 2011 Apr. 12, 2011 Oct. 19, 2010 Oct. 26, 2010 Apr. 26, 2011 Feb. 15, 2011 Oct. 05, 2010 Oct. 12, 2010 Sep. 21, 2010 Jan. 11, 2011 Feb. 22, 2011 Nov. 23, 2010 Sep. 28, 2010 Apr. 05, 2011
